Subscribe to our Newsletters !!
Drug quality is defined not only how a drug is man
Eppendorf is launching the new VisioNize® box 2,
The journey and merging of sperm and egg cells is
This year, the Hamburg based life sciences company
Alembic Pharmaceutica
Since it’s an ingredient in so many foods, you h
In a world constantly in motion, Microbioz India r
The World Health Organization (WHO) exhorted the world to keep administering AstraZeneca’s COVID-19 shots on Friday, including its endorsement to that of European and British regulators after worries over blood clotting.
“We urge countries to continue using this important COVID-19 vaccine,” WHO Director General Tedros Adhanom Ghebreyesus told a news conference in Geneva.
He was speaking after the international health body’s vaccine safety panel said available data about the AstraZeneca shot did not point to any general increase in clotting conditions.
European and British authorities also said this week that the advantages of AstraZeneca’s shot outweighed the dangers, prompting various nations to lift their suspensions.
“The AstraZeneca vaccine is particularly important because it accounts for more than 90% of the vaccines being distributed through COVAX,” Tedros added, speaking to a WHO-led worldwide vaccine-sharing scheme.
“There is no question. COVID-19 is a deadly disease, and the Oxford-AstraZeneca vaccine can stop it. It’s also important to remember that COVID-19 itself can cause blood clots and low platelets.”
The WHO’s global advisory committee on vaccine safety said in a statement that the AstraZeneca vaccine had a”favorable benefit-risk profile” and”tremendous potential” to prevent infections and reduce deaths.
“While very rare and unique thromboembolic events in combination with thrombocytopenia, such as cerebral venous sinus thrombosis (CVST), have also been reported after vaccination with the AstraZeneca COVID-19 vaccine in Europe, it is not certain that they’ve been caused by vaccination,” it said.
